Persistent Spinal Pain Syndrome Type 2 Clinical Trials

4 recruiting

Frequently Asked Questions

Common questions about Persistent Spinal Pain Syndrome Type 2 clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting

Evaluation of Medication Tapering on the Sensitivity of the Spinal Cord Using Closed-Loop Spinal Cord Stimulation (Pilot Study)

Neurophysiological Sensitivity to Spinal Cord StimulationFailed Back Surgery Syndrome (FBSS)Persistent Spinal Pain Syndrome Type 2 (PSPS-T) Lower Spine
Brai²n20 enrolled1 locationNCT07502612
Recruiting

Neurophysiological Effects of Medication Tapering During Treatment With Spinal Cord Stimulation

Persistent Spinal Pain Syndrome Type 2 (PSPS-T2), Lower SpineSpinal Cord Sensitivity to NeurostimulationNeurophysiological Sensitivity to Spinal Cord Stimulation
Brai²n50 enrolled1 locationNCT07413731
Recruiting

Neuronal Activation Accuracy in Closed-loop Spinal Cord Stimulation

Chronic PainNeuropathic PainPersistent Spinal Pain Syndrome Type 2
Karel Hanssens12 enrolled1 locationNCT06775535
Recruiting
Not Applicable

Effects of Active Versus Passive Recharge Burst Spinal Cord Stimulation on Pain Experience in Persistent Spinal Pain Syndrome Type 2: a Multicenter Randomized Trial (BURST-RAP Study)

Failed Back Surgery SyndromePersistent Spinal Pain Syndrome Type 2
Rijnstate Hospital96 enrolled6 locationsNCT05421273
Recruiting

Differential Target Multiplexed Spinal Cord Stimulation

Failed Back Surgery SyndromePersistent Spinal Pain Syndrome Type 2
Moens Maarten250 enrolled14 locationsNCT05068011
Recruiting
Not Applicable

Pain Medication Tapering for Patients With Persistent Spinal Pain Syndrome Type 2, Treated With Spinal Cord Stimulation.

Spinal Cord StimulationPersistent Spinal Pain Syndrome Type 2
Moens Maarten195 enrolled3 locationsNCT05861609